Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 janv. 2026 17h20 HE | Source: RECORDATI

RECORDATI ANNUNCIA UNA COLLABORAZIONE STRATEGICA CON MODERNA PER SVILUPPARE E COMMERCIALIZZARE A LIVELLO GLOBALE mRNA-3927 PER IL TRATTAMENTO DELL’ACIDEMIA PROPIONICA

mRNA-3927 si inserisce strategicamente nel portafoglio delle malattie rare metaboliche di Recordati La collaborazione unisce l’expertise di Moderna nella tecnologia mRNA per i disturbi metabolicirari...
29 janv. 2026 17h20 HE | Source: RECORDATI

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA

RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
29 janv. 2026 09h29 HE | Source: Research and Markets

$33.84 Bn Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis and Growth Forecasts to 2033

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Gene Therapy, RNA-based Therapies), Service,...
15 janv. 2026 10h05 HE | Source: Research and Markets

mRNA Quality Monitoring Market Forecast Report 2025-2033: Surge in mRNA-Based Therapeutics & Vaccines, Technology Innovation & Outsourcing Trends

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "mRNA Quality Monitoring Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.The global mRNA quality monitoring market...
12 nov. 2025 05h09 HE | Source: Research and Markets

RNA Targeting Small Molecules Therapeutics Global Research Report 2025: 7.03 Billion Market Opportunities and Strategies to 2034 - Expansion in AI-driven Drug Discovery, Alliances, Emerging Markets

Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's...
31 oct. 2025 14h48 HE | Source: BCC Research LLC

China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030

Boston, Oct. 31, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Chinese Market for DNA Sequencing” is projected to grow from $1.2 billion in 2025 to $3.1 billion by...
29 oct. 2025 14h12 HE | Source: BCC Research LLC

mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030

Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...
15 oct. 2025 11h39 HE | Source: Eascra Biotech

Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”

Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next Big Things in Tech list for 2025.
14 oct. 2025 07h30 HE | Source: Aanastra Inc

Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x)

Aanastra Inc to present preclinical data for in vivo CAR-T and p53 RNA programs leveraging its proprietary PEP-NP™ peptide delivery technology
02 sept. 2025 15h06 HE | Source: Association of American Physicians and Surgeons

Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons

While mRNA biologics are a transformative frontier, modified mRNA COVID vaccines can disrupt every body system. Urgent scrutiny and acountability needed.

Page suivante